Safe Medicines Group Warns of Compounded GLP-1 Crisis
Partnership for Safe Medicines briefing targets patients and policymakers on risks in the compounded weight-loss drug market.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 15 14:18 ETSource: Partnership for Safe Medicines
The wire
- 01Partnership for Safe Medicines published a briefing on compounded GLP-1 risks.
- 02Advocacy pressure could shape state and federal policy on compounded obesity drugs.
- 03No specific legislative or enforcement steps are cited in the source.
From the source
Read at news.google.comCompounded GLP-1 Crisis: What Patients and Policymakers Need to Know